197 related articles for article (PubMed ID: 2958429)
21. Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
Mustakallio KK
Acta Derm Venereol; 1980; 60(2):169-71. PubMed ID: 6155030
[TBL] [Abstract][Full Text] [Related]
22. Low concentration dithranol and coal tar (Psorin) in psoriasis: a comparison with alcoholic coal tar extract and allantoin (Alphosyl).
Harrington CI
Br J Clin Pract; 1989 Jan; 43(1):27-9. PubMed ID: 2590619
[TBL] [Abstract][Full Text] [Related]
23. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
24. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
25. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
26. [Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
Schulze HJ; Steigleder GK
Z Hautkr; 1984 May; 59(10):654-6. PubMed ID: 6741204
[TBL] [Abstract][Full Text] [Related]
27. [Potential factors influencing dithranol erythema].
Richter G; Barth J
Dermatol Monatsschr; 1986; 172(5):272-5. PubMed ID: 3721033
[No Abstract] [Full Text] [Related]
28. Effects of dithranol on neutrophil superoxide generation in patients with psoriasis.
Kavanagh GM; Burton JL; Donnell VO
Br J Dermatol; 1996 Feb; 134(2):234-7. PubMed ID: 8746335
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
[TBL] [Abstract][Full Text] [Related]
30. Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
Christensen OB; Holst R; Hradil E; Brolund L
Acta Derm Venereol Suppl (Stockh); 1989; 146():96-100; discussion 101. PubMed ID: 2609898
[TBL] [Abstract][Full Text] [Related]
31. An open, parallel groups, study of the importance of thoroughness of application in the treatment of psoriasis with a dithranol cream (Micanol).
Mørk NJ; Austad J; Brolund L
Acta Derm Venereol Suppl (Stockh); 1992; 172():23-4. PubMed ID: 1585758
[TBL] [Abstract][Full Text] [Related]
32. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
Göransson AM; Kolari PJ; Mustakallio KK
Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
[TBL] [Abstract][Full Text] [Related]
33. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
Brandt H
Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
[TBL] [Abstract][Full Text] [Related]
34. Treatment of chronic plaque psoriasis with dithranol and urea creams: a double-blind study.
Young MM
Pharmatherapeutica; 1982; 3(2):86-92. PubMed ID: 7048339
[TBL] [Abstract][Full Text] [Related]
35. [Effect of tar and dithranol on fibrinolysis in treatment of psoriasis].
Arenberger P; Buchtová L
Dermatol Monatsschr; 1990; 176(11):699-700. PubMed ID: 2083610
[TBL] [Abstract][Full Text] [Related]
36. The incidence of allergic contact dermatitis in patients with psoriasis vulgaris.
Clark AR; Sherertz EF
Am J Contact Dermat; 1998 Jun; 9(2):96-9. PubMed ID: 9601910
[TBL] [Abstract][Full Text] [Related]
37. [Suppression of cignolin-induced erythema by tar].
Schulze HJ
Z Hautkr; 1984 May; 59(10):659-62. PubMed ID: 6741205
[No Abstract] [Full Text] [Related]
38. Intolerance and contact allergy to tar and dithranol in psoriasis.
Burden AD; Muston H; Beck MH
Contact Dermatitis; 1994 Sep; 31(3):185-6. PubMed ID: 7821017
[No Abstract] [Full Text] [Related]
39. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
Göring HD; Voss M
Hautarzt; 1984 Mar; 35(3):148-51. PubMed ID: 6715170
[TBL] [Abstract][Full Text] [Related]
40. Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis.
Greaves MW
Int J Clin Pharmacol Res; 1986; 6(4):315-6. PubMed ID: 2428761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
